- Marketwired•3 months ago
Therapeutic Solutions International, Inc. announced today the addition of four new consumer products to our nutraceutical division. The four new products will all be in Liposome formulas. Many orally consumed ...
- Marketwired•5 months agoTherapeutic Solutions International's Subsidiary MolecuVax, Inc. Announces Licensing of "Universal Cancer Vaccine" With Demonstrated Efficacy in Breast Cancer
Therapeutic Solutions International, Inc., announced today the signing of an exclusive license agreement between its subsidiary, MolecuVax, Inc., and UniVax, LLC covering composition of matter of a new ...
- Marketwired•5 months agoTherapeutic Solutions International Files Patent Covering ProJuvenol(C) and Its Active Ingredient Pterostilbene
Therapeutic Solutions International, Inc., announced today the filing of a patent application covering the use of ProJuvenol© and its active ingredient pterostilbene for augmentation of stem cell activity. ...
Therapeutic Solutions International, Inc. (TSOI)
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-5.50|
|Avg Vol (3m)||12,500|
|Dividend & Yield||N/A (N/A)|